DANIELLE MATHIS: Open Payments
NPI 1982088597 · EUSTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 32 payments from 9 companies in 2025. Trend: 2023 $441 · 2024 $514 · 2025 $831
Food & beverage: $731Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $246 |
| Lilly USA, LLC | 7 | $242 |
| AstraZeneca Pharmaceuticals LP | 5 | $142 |
| Novo Nordisk Inc | 4 | $88 |
| Exact Sciences Corporation | 2 | $37 |
| Dexcom, Inc. | 1 | $22 |
| SHIELD THERAPEUTICS INC | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $14 |
Products named: MOUNJARO, Veozah, AIRSUPRA, Ozempic, The Cologuard Plus Collection Kit, KISUNLA, Dexcom G6 Transmitter, ACCRUFER.
Industry payments across FL — which companies pay providers there.
